Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Non-Current Deffered Revenue (2017 - 2021)

Solid Biosciences' Non-Current Deffered Revenue history spans 3 years, with the latest figure at $2.3 million for Q3 2021.

  • For Q3 2021, Non-Current Deffered Revenue changed N/A year-over-year to $2.3 million; the TTM value through Sep 2021 reached $2.3 million, changed N/A, while the annual FY2020 figure was $10.4 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue for Q3 2021 was $2.3 million at Solid Biosciences, down from $4.3 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $10.4 million in Q4 2020 and bottomed at $2.3 million in Q3 2021.
  • The 3-year median for Non-Current Deffered Revenue is $4.3 million (2021), against an average of $5.4 million.